Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Bioengineered Gastrointestinal Tissues with Fibroblast-Induced Shapes

Zhou L. et al, (2021), ADVANCED FUNCTIONAL MATERIALS, 31

Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution

Louphrasitthiphol P. et al, (2020), Molecular Cell, 79, 472 - 487.e10

BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export

Ngeow KC. et al, (2018), Proceedings of the National Academy of Sciences, 115

Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma

Falletta P. et al, (2017), Genes & Development, 31, 18 - 33

DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma

Gupta A. et al, (2014), Annals of Oncology, 25, 968 - 974

P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma

Ong CC. et al, (2013), JNCI: Journal of the National Cancer Institute, 105, 606 - 607

Include forthcoming?

In this section